NEVVI Medicare utilization intelligence
+ Build a code basket
Medicare Pennsylvania · CY2024

Who bills the most Injection, oxaliplatin, 0.5 mg (J9263) to Medicare in Pennsylvania?

Medicare Part B FFS · CY2024 · as published by CMS
4
Billing groups
110,190
Named-group FFS services
$1,225,770
Named-group submitted charges
$11
Avg charge / service
$0
Avg allowed / service
Top-5 concentration
0%
Independent share

4 physician groups billed Injection, oxaliplatin, 0.5 mg (J9263) to Medicare fee-for-service in Pennsylvania in 2024; independent (non-hospital-affiliated) groups deliver 0%.

J9263 — Injection, oxaliplatin, 0.5 mg · Source: CMS Medicare Physician & Other Practitioners PUF (Part B), CY2024 release. Medicare fee-for-service only.

Snapshot covers the whole Pennsylvania market — the table below shows the top 100 groups (free tier).

Payer-mix context

Medicare fee-for-service covers 46% of Medicare in Pennsylvania; Medicare Advantage penetration 45% → 54% since 2020.

Market structure — concentration, independent share, and the consolidation trend for this market — is part of the market analytics platform — built, not launched yet. Notify me at launch →
#Physician groupCityStSpecialty Providers J9263 svcs Share*Phone
1 MEDICAL ONCOLOGY ASSOCIATES OF WYOMING VALLEY, PC KINGSTONPAMEDICAL ONCOLOGY 2 39,600 35.9% (570) 288-7231
2 CANCER CARE ASSOCIATES OF YORK, INC. YORKPAHEMATOLOGY/ONCOLOGY 15 34,470 31.3% (717) 741-9229
3 ALLIANCE CANCER SPECIALISTS P.C. LANGHORNEPAHEMATOLOGY/ONCOLOGY 44 21,500 19.5% (215) 750-5050
4 HEMATOLOGY AND ONCOLOGY ASSOCIATES OF NORTHEASTERN PA PC DUNMOREPAHEMATOLOGY/ONCOLOGY 7 14,620 13.3% (570) 342-3675

*Share of Pennsylvania's disclosed Medicare-FFS services for J9263, counted once per clinician. Volume is placed in the state it was billed from, so this page ranks the groups actually billing J9263 in Pennsylvania — including groups registered elsewhere ("City" is each group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group.

How to read this. Figures are Medicare fee-for-service only — not all-payer — from the CMS Medicare Physician & Other Practitioners Public Use File (Part B), CY2024 release. CMS suppresses any provider×code row under 11 beneficiaries, so a missing group means "suppressed," never zero. "Charges" are provider-submitted amounts, not payments. Groups are ranked by measured service volume attributed to clinicians in exactly one group — clinicians affiliated with several groups are listed in rosters but never volume-attributed to a single group — a direct read of the public record, not a rating or quality score. Full method: Methods & Sources.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →